# Kejako

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kejako

- Industry: Medical Devices & Equipment
- Headquarters: Saint-Etienne, France
- Website: www.kejako.com/
- Total disclosed funding: $0.8M
- Latest round: Seed (Mar 21, 2018)
- Investors on record: 1

## About

Based in Saint-Etienne, France, and founded in 2015, Kejako SA operates as a medical equipment manufacturing company specializing in ophthalmic anti-aging solutions. Gilles Bos and David Enfrun (CEO) are the co-founders of the company. In July 2022, Kejako SA raised venture funding from Business Angels Suisse.

The company offers a personalized anti-aging laser treatment known as phakorestoration, which is designed to rejuvenate the lens material itself, allowing the lens to regain its ability to change shape and thereby restore comfortable accommodation. Phakorestoration is performed using a femtosecond laser that precisely targets and softens the lens tissues, enabling them to deform again and restore visual accommodation. The firm’s treatment provides midlifers with near vision without the need for reading glasses. Kejako's technique is customized for each patient's eyesight using its patented numerical model that replicates and fits the eye's biometry. In addition, the company’s advanced numerical simulation technology adapts to each patient's biometry and state of presbyopia to predict the optimal treatment pattern and performance.

## Funding rounds

- Seed, Mar 21, 2018, $0.8M — Fongit Seed Invest

## Investors

- Fongit Seed Invest (https://capitalatlas.ai/funds/fongit-seed-invest) — Seed